First Time Loading...

Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 19.75 CNY -1% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one Pharmaron Beijing Co Ltd stock under the Base Case scenario is 58.97 CNY. Compared to the current market price of 19.75 CNY, Pharmaron Beijing Co Ltd is Undervalued by 67%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
58.97 CNY
Undervaluation 67%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
96
vs Industry
56
Median 3Y
7.5
Median 5Y
6.9
Industry
3.9
Forward
2.6
More Details
21.9
P/E
P/E
Price to Earnings
21.9
vs History
96
vs Industry
31
Median 3Y
38.8
Median 5Y
38.8
Industry
30.3
Forward
18.8
More Details
12.7
P/OCF
P/OCF
Price to OCF
12.7
vs History
90
vs Industry
39
Median 3Y
31.1
Median 5Y
26.6
Industry
23.2
More Details
10
P/FCFE
P/FCFE
Price to FCFE
10
vs History
53
vs Industry
30
Median 3Y
13.8
Median 5Y
13.8
Industry
26.9
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
95
vs Industry
37
Median 3Y
6
Median 5Y
5.2
Industry
2.5
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
96
vs Industry
48
Median 3Y
7.6
Median 5Y
6.9
Industry
3.8
Forward
2.8
More Details
9.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.2
vs History
96
vs Industry
38
Median 3Y
21.8
Median 5Y
19.5
Industry
7.7
More Details
21.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.2
vs History
93
vs Industry
23
Median 3Y
40.2
Median 5Y
35.7
Industry
16.8
Forward
12
More Details
21.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
21.2
vs History
93
vs Industry
29
Median 3Y
40.2
Median 5Y
35.7
Industry
22
Forward
17.7
More Details
13.7
EV/OCF
EV/OCF
Enterprise Value to OCF
13.7
vs History
90
vs Industry
38
Median 3Y
31
Median 5Y
26.8
Industry
21.1
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-195.9
Median 5Y
-84
Industry
27.6
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
96
vs Industry
47
Median 3Y
4.4
Median 5Y
4.3
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
Pharmaron Beijing Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Pharmaron Beijing Co Ltd
SZSE:300759
35B CNY 3 21.9 21.2 21.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
220.8B USD 5.2 36.8 22.8 33.4
US
Danaher Corp
NYSE:DHR
180.7B USD 4.1 22.4 16.3 20.1
US
IQVIA Holdings Inc
NYSE:IQV
40.6B USD 2.7 29.9 16.3 25.3
US
Agilent Technologies Inc
NYSE:A
40.4B USD 6 32.7 26.1 31.4
CH
Lonza Group AG
SIX:LONN
37B CHF 5.5 56.5 19.4 28.5
KR
Samsung Biologics Co Ltd
KRX:207940
55.2T KRW 14.9 64.3 33.9 48.8
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.8B USD 9.1 47.1 32.7 39.7
IE
ICON PLC
NASDAQ:ICLR
24.8B USD 3 36.3 16.5 25.3
FR
Sartorius Stedim Biotech SA
PAR:DIM
19B EUR 7 74.5 32.1 52.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.